Moreover, even at extremely low doses, IR‐LND@Lip was able to significantly inhibit the OCR of tumor cells (Figure 2B) and efficiently downregulate the expression of PD‐L1 and HIF‐1α protein in tumor cells (Figure 2C; Figures S7 and S8, Supporting Information). This evidence concerns the gene HIF1A and neoplasm.